EMJ Hematology 10.1 2022

In this issue

Welcome to our latest issue of EMJ Hematology, which brings you quality content on the latest developments in the field and a review of the European Hematology Association (EHA) 2022 Hybrid Congress, with key highlights from the event. Featured articles include a review of the social impact and quality of life for patients with β-thalassaemia, and an article on how helical tomotherapy may be used as a valid and effective treatment for compressive atelectasis due to extramedullary haematopoiesis.

Rate this content's potential impact on patient outcomes

Average rating / 5. Vote count:

No votes so far! Be the first to rate this content.